CA2514899A1 - Methodes de modulation de cellules t effectrices de memoire et compositi ons associees - Google Patents

Methodes de modulation de cellules t effectrices de memoire et compositi ons associees Download PDF

Info

Publication number
CA2514899A1
CA2514899A1 CA002514899A CA2514899A CA2514899A1 CA 2514899 A1 CA2514899 A1 CA 2514899A1 CA 002514899 A CA002514899 A CA 002514899A CA 2514899 A CA2514899 A CA 2514899A CA 2514899 A1 CA2514899 A1 CA 2514899A1
Authority
CA
Canada
Prior art keywords
lfa
polypeptide
amino acid
subject
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002514899A
Other languages
English (en)
Inventor
Daniel Magilavy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas US LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority claimed from CA002339299A external-priority patent/CA2339299C/fr
Publication of CA2514899A1 publication Critical patent/CA2514899A1/fr
Abandoned legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002514899A 1998-08-31 1999-08-31 Methodes de modulation de cellules t effectrices de memoire et compositi ons associees Abandoned CA2514899A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9845698P 1998-08-31 1998-08-31
US60/098,456 1998-08-31
CA002339299A CA2339299C (fr) 1998-08-31 1999-08-31 Methodes de modulation de cellules t effectrices de memoire et compositions associees

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002339299A Division CA2339299C (fr) 1998-08-31 1999-08-31 Methodes de modulation de cellules t effectrices de memoire et compositions associees

Publications (1)

Publication Number Publication Date
CA2514899A1 true CA2514899A1 (fr) 2000-03-09

Family

ID=35589259

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002514899A Abandoned CA2514899A1 (fr) 1998-08-31 1999-08-31 Methodes de modulation de cellules t effectrices de memoire et compositi ons associees

Country Status (1)

Country Link
CA (1) CA2514899A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8399496B2 (en) 2000-12-27 2013-03-19 Gilead Sciences, Inc. Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections
US9533000B2 (en) 2000-12-27 2017-01-03 Gilead Sciences, Inc. Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8399496B2 (en) 2000-12-27 2013-03-19 Gilead Sciences, Inc. Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections
US8841286B2 (en) 2000-12-27 2014-09-23 Gilead Sciences, Inc. Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections
US9345663B2 (en) 2000-12-27 2016-05-24 Gilead Sciences, Inc. Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections
US9533000B2 (en) 2000-12-27 2017-01-03 Gilead Sciences, Inc. Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections

Similar Documents

Publication Publication Date Title
CA2339299C (fr) Methodes de modulation de cellules t effectrices de memoire et compositions associees
US7125670B2 (en) Ligand (ACT-4-L) to a receptor on the surface of activated CD4+T-cells
DK2650020T3 (en) Trimeric OX40 immunoglobulin fusion protein and methods for applications.
JP2009240311A (ja) 活性化されたｔ細胞の表面上のレセプタ：ａｃｔ−４
JP2003089654A (ja) リンパ球機能関連抗原３のｃｄ２結合ドメイン
EP0786255B1 (fr) Procédés d'amélioration de la tolérance des greffes allogènes ou xénogènes par administration d'une protéine liante à LFA-3 ou CD2
CA2220098A1 (fr) Ligand cd6
EP1637155A1 (fr) Méthode et compositions pour moduler les cellules T mémoire effectrices, en utilissant un agent se liant à CD2
AU2003259616B2 (en) Method of Modulating Memory Effector T-Cells and Compositions
HK1038186B (en) Modulation of memory effector t-cells with a cd2 binding agent
HK1087044A (en) Method of modulating memory effector t-cells using a cd2-binding agent, and compositions
AU2005203741A1 (en) Method of Modulating Memory Effector T-Cells and Compositions
HK1001462B (en) Ligand (act-4-l) to a receptor on the surface of activated cd4+ t-cells

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead